<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01501578</url>
  </required_header>
  <id_info>
    <org_study_id>GERMOP-004</org_study_id>
    <nct_id>NCT01501578</nct_id>
  </id_info>
  <brief_title>Pulmonary Fibrosis and Telomerase Mutation Study</brief_title>
  <official_title>Phenotype of Pulmonary Fibrosis Associated With a Mutation of Telomerase</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bichat Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is an observational and retrospective study of patients with pulmonary fibrosis
      associated or not with telomerase mutation.

      The purpose of this study is to describe in detail the cases with telomerase mutation in
      terms of features on CT scan, respiratory function and evolution, in comparison to control
      subjects with idiopathic pulmonary fibrosis and no telomerase mutation identified or family
      history.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Two &quot;control&quot; subjects will be enrolled for one subject with telomerase mutation.

      The data are all the results of investigations conducted for the diagnosis of idiopathic
      pulmonary fibrosis and during routine follow up of patients.

      The CT scans will reviewed centrally to homogenize the description.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Description of imaging pattern</measure>
    <time_frame>at baseline only</time_frame>
    <description>Description of imaging pattern on representative CT scan at diagnosis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pathology of the lung</measure>
    <time_frame>at baseline only</time_frame>
    <description>description of pathological pattern</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary function tests</measure>
    <time_frame>from diagnosis to last follow-up, for an average of one year</time_frame>
    <description>analyze the respiratory function</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">81</enrollment>
  <condition>Pulmonary Fibrosis</condition>
  <arm_group>
    <arm_group_label>telomerase mutation</arm_group_label>
    <description>Patients with interstitial lung disease and telomerase mutation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <description>Patients with idiopathic pulmonary fibrosis and without telomerase mutation</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      one blood sample is collected for genetic analysis of telomerase mutation
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients with pulmonary fibrosis with and without telomerase mutation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diffuse interstitial lung disease on CT scan

          -  Telomerase mutation analysis

        Exclusion Criteria:

          -  Presence of connective tissue disease, or pneumoconiosis or drug induced lung disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>vincent Cottin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospices civils de Lyon / University Lyon I</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Louis Pradel Hospital (BÃ¢timent A4)</name>
      <address>
        <city>Lyon</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://maladies-pulmonaires-rares.fr/</url>
    <description>website National French Reference Center for rare lung diseases</description>
  </link>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 13, 2011</study_first_submitted>
  <study_first_submitted_qc>December 27, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 29, 2011</study_first_posted>
  <last_update_submitted>February 19, 2018</last_update_submitted>
  <last_update_submitted_qc>February 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires</investigator_affiliation>
    <investigator_full_name>Vincent COTTIN</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Pulmonary fibrosis</keyword>
  <keyword>Telomerase mutation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Pulmonary Fibrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Under analysis, publication in preparation</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

